Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -5.6 | $ -405.83M | 1 | 72.47M |
3/31/2025 | $ -4.7 | $ -338.38M | 1 | 71.97M |
12/31/2024 | $ -4.01 | $ -253.58M | 1 | 63.18M |
9/30/2024 | $ -2.9 | $ -187.11M | 1 | 64.63M |
6/30/2024 | $ -3.99 | $ -233.83M | 1 | 58.56M |
3/31/2024 | $ -2.54 | $ -148.5M | 1 | 58.37M |
12/31/2023 | $ -1.42 | $ -72.76M | 1 | 51.29M |
9/30/2023 | $ -0.31 | $ -17.77M | 1 | 56.78M |
6/30/2023 | $ 0.36 | $ 17.6M | 1 | 48.5M |
3/31/2023 | $ -2.13 | $ -90.19M | 1 | 42.35M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for PHATHOM PHARMACEUTICALS INC is calculated as follows: Equity [ $ 156.39M ] / (Shares WA [ 33.37M ] * Share Factor [ 1 ])
(=) BVPS [ $ 4.69 ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.85 |
average | $ 10.28 |
median | $ 6.03 |
std | $ 12.44 |